Instruments — Consolidated revenues
Products & Services · Consolidated revenuesThermo Fisher Scientific Instruments — Consolidated revenues increased by 2.4% to $1.81B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $1.77B to $1.81B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong demand for capital equipment and successful product innovation, while a decrease may indicate market saturation or a slowdown in customer capital expenditure budgets.
Detailed definition
This metric represents the total net sales generated by the business unit focused on scientific instruments and analytic...
Peer comparison
Comparable to capital equipment revenue segments in life sciences and analytical instrumentation peers, often sensitive to macroeconomic cycles and R&D spending trends.
tmo_segment_instruments_consolidated_revenuesHistorical Data
| Q2 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84B | $1.91B | $2.01B | $1.91B | $1.91B | $1.91B | $1.91B | $1.77B | $1.81B |
| QoQ Change | — | +3.5% | +5.4% | -4.9% | +0.0% | +0.0% | +0.0% | -7.5% | +2.4% |
| YoY Change | — | — | +9.1% | +0.2% | -4.9% | — | — | -7.5% | +2.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's instruments — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported instruments — consolidated revenues of $1.81B in Q3 2025.
- How has Thermo Fisher Scientific's instruments — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's instruments — consolidated revenues increased by 2.4% year-over-year, from $1.77B to $1.81B.
- What does instruments — consolidated revenues mean?
- The total revenue generated from the sale of scientific instruments and analytical hardware equipment.